Physician profile
Michelle E Holcomb
NPI 1578583753
$5,065.05
in general payments reported to CMS, 2019-2025
41 companies · $1,262 in 2025
The $1,262 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.13 · 2022: $1,179 · 2023: $1,527 · 2024: $1,031 · 2025: $1,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,820.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,014.54 | 2022-2025 | |
| Lilly USA, LLC | $516.17 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Corcept Therapeutics | $485.34 | 2024-2025 | Korlym |
| Novo Nordisk INC | $482.29 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $301.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $293.98 | 2022-2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $174.75 | 2021-2024 | Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.16 | 2021-2025 | Jardiance |
| Amgen INC. | $139.85 | 2023 | Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $135.27 | 2022-2025 | |
| Pfizer INC. | $119.74 | 2023-2025 | |
| Inspire Medical Systems, INC. | $118.52 | 2024 | Inspire |
| Antares Pharma, INC. | $112.95 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Verity Pharmaceuticals INC. | $106.95 | 2024-2025 | Tlando |
| Otsuka America Pharmaceutical, INC. | $100.01 | 2023-2024 | Rexulti |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Holcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.